[1]
Mutua, V. et al. 2022. Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs. Acta Biomedica Atenei Parmensis. 93, 1 (Mar. 2022), e2022014. DOI:https://doi.org/10.23750/abm.v93i1.12208.